Form 13G Establishment Labs Holdings Inc. For: 19 February

An investor filed Form 13G with the U.S. Securities and Exchange Commission on February 19, 2026, disclosing beneficial ownership of more than 5% of Establishment Labs Holdings Inc., a regulatory requirement for significant shareholders. The filing, submitted as of the close of business on February 19, represents the investor's acquisition of a substantial stake in the medical aesthetics company, providing transparency to the market about ownership positions that could potentially influence company decisions or stock performance. This regulatory disclosure comes amid a turbulent market where U.S. stocks have recently declined following the release of hawkish Federal Reserve minutes, with major retailers like Walmart also facing pressure after issuing guidance that fell short of expectations, while gold prices have remained relatively stable as investors balance geopolitical tensions against the Federal Reserve's monetary policy stance.